, Plenary
Group 6: Exemptions-in relation to cotton buds (Amendments 31, 32, 33, 35, 36, 37, 38)
Yes.
, Plenary
Group 6: Exemptions-in relation to cotton buds (Amendments 31, 32, 33, 35, 36, 37, 38)
Is it being moved, Janet Finch-Saunders?
, Plenary
Group 6: Exemptions-in relation to cotton buds (Amendments 31, 32, 33, 35, 36, 37, 38)
Amendment 32, is it being moved?
, Plenary
Group 6: Exemptions-in relation to cotton buds (Amendments 31, 32, 33, 35, 36, 37, 38)
The question is that amendment 31 be agreed to. Does any Member object? [Objection.] Yes, there is objection. Therefore, we will proceed to a vote on amendment 31. Open the vote. Close the vote. In favour 26, no abstentions, 28 against. Therefore, amendment…
, Plenary
Group 6: Exemptions-in relation to cotton buds (Amendments 31, 32, 33, 35, 36, 37, 38)
Janet Finch-Saunders to respond.
, Plenary
Group 6: Exemptions-in relation to cotton buds (Amendments 31, 32, 33, 35, 36, 37, 38)
I don't have any other speakers on this, other than the Minister to respond.
, Plenary
Group 6: Exemptions-in relation to cotton buds (Amendments 31, 32, 33, 35, 36, 37, 38)
We'll move next to group 6, which relates to exemptions in relation to cotton beds. The lead amendment in the group is amendment 31, and I call on Janet Finch-Saunders to move and speak to the lead amendment and the other amendments in the group. Janet…
, Plenary
Group 5: Exemptions in relation to pharmacy medicine (Amendments 2, 3, 4, 5)
The question is that amendment 58 be agreed to. Does any Member object? [Objection.] There is objection. We will therefore proceed to a vote on amendment 58. Open the vote. Close the vote. In favour 12, no abstentions, 42 against. And therefore, amendment 58…
, Plenary
Group 5: Exemptions in relation to pharmacy medicine (Amendments 2, 3, 4, 5)
We now move to amendment 58, which was debated as part of group 4. Delyth Jewell, is amendment 58 moved?
, Plenary
Group 5: Exemptions in relation to pharmacy medicine (Amendments 2, 3, 4, 5)
I have no other speakers on this group, so the question is that amendment 2 be agreed to. Does any Member object? There is no objection, and therefore, amendment 2 is agreed.
, Plenary
Group 5: Exemptions in relation to pharmacy medicine (Amendments 2, 3, 4, 5)
We move now to group 5, which relates to exemptions in relation to pharmacy medicine. The lead amendment in the group is amendment 2, and I call on the Minister to move and speak to the lead amendment and the other amendments in the group. Minister.
, Plenary
Group 4: Manufacture of prohibited single-use plastic products (Amendments 57, 58, 59, 16, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 30, 56)
The question is that amendment 57 be agreed to. Does any Member object? [Objection.] There is objection. We will therefore move to a vote on amendment 57. Open the vote. Close the vote. In favour 13, no abstentions, 41 against. And therefore amendment 57 is…
, Plenary
Group 4: Manufacture of prohibited single-use plastic products (Amendments 57, 58, 59, 16, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 30, 56)
Delyth Jewell to reply.
, Plenary
Group 4: Manufacture of prohibited single-use plastic products (Amendments 57, 58, 59, 16, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 30, 56)
Group 4 is the next group of amendments, and this group relates to the manufacture of prohibited single-use plastic products. The lead amendment in this group is amendment 57, and I call on Delyth Jewell to move and speak to the lead amendment and the other…
, Plenary
Group 3: Guidance (Amendments 15, 17)
The question is that amendment 15 be agreed to. Does any Member object? [Objection.] Yes, there is objection. Therefore, we'll proceed to a vote on amendment 15. Open the vote. Close the vote. In favour 26, no abstentions, 28 against. Therefore, amendment 15…
, Plenary
Group 3: Guidance (Amendments 15, 17)
Janet Finch-Saunders to respond.
, Plenary
Group 3: Guidance (Amendments 15, 17)
Group 3 is next. This group of amendments relates to guidance. The lead amendment in this group is amendment 15, and I call on Janet Finch-Saunders to move and speak to the lead amendment and the other amendment in the group—Janet Finch-Saunders.
, Plenary
Group 2: Electronic cigarettes (Amendments 6, 9, 10, 7, 8)
No objection to amendment 1. Therefore, amendment 1 is agreed.
, Plenary
Group 2: Electronic cigarettes (Amendments 6, 9, 10, 7, 8)
Is there any objection?
, Plenary
Group 2: Electronic cigarettes (Amendments 6, 9, 10, 7, 8)
Yes, it's moved. Therefore, is there any objection to amendment 1? Objection?
, Plenary
Group 2: Electronic cigarettes (Amendments 6, 9, 10, 7, 8)
We now move to a vote on amendment 1, which was debated as part of group 1. Minister, do you move the amendment?
, Plenary
Group 2: Electronic cigarettes (Amendments 6, 9, 10, 7, 8)
The question is that amendment 6 be agreed to. Does any Member object? [Objection.] Yes, there is objection. Therefore, we will move to a vote on amendment 6. Open the vote. Close the vote. In favour 13, no abstentions, 40 against. Therefore, amendment 6 is…
, Plenary
Group 2: Electronic cigarettes (Amendments 6, 9, 10, 7, 8)
Rhys ab Owen to respond.
, Plenary
Group 2: Electronic cigarettes (Amendments 6, 9, 10, 7, 8)
Minister.
, Plenary
Group 2: Electronic cigarettes (Amendments 6, 9, 10, 7, 8)
The next group of amendments relates to electronic cigarettes. The lead amendment in the group is amendment 6, and I call on Rhys ab Owen to move and speak to the amendment. Rhys ab Owen.